Overview

RCT of Gastric ESD With or Without Epineprhine Added Solution

Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
This is an international multi-center randomised controlled study comparing outcomes of gastric endoscopic submucosal dissection (ESD) with or without addition of epinephrine in the submucosal injection solution.
Phase:
Phase 3
Details
Lead Sponsor:
Chinese University of Hong Kong
Collaborators:
Changi General Hospital
Fukuoka University
Ishikawa Prefectural Central Hospital
JCHO Osaka Hospital
Kosin University Gospel Hospital
Kyoto 2nd Red Cross Hospital
Machida General Hospital
Nara City Hospital
Osaka International Cancer Institute
Shizuoka Cancer Center
Wakayama Red Cross Hospital
Treatments:
Epinephrine
Epinephryl borate
Pharmaceutical Solutions
Racepinephrine